Sanbo Hospital Management Group Limited (SHE:301293)
China · Delayed Price · Currency is CNY 70.16
+0.83 (1.20%)
At close: May 8, 2026
SHE:301293 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,765 | 1,713 | 1,419 | 1,305 | 1,064 | 1,132 |
Other Revenue | 12.27 | 12.27 | 10.6 | 8.39 | 5.97 | 4.82 |
| 1,777 | 1,725 | 1,429 | 1,313 | 1,070 | 1,137 | |
Revenue Growth (YoY) | 19.58% | 20.69% | 8.84% | 22.73% | -5.90% | 15.20% |
Cost of Revenue | 1,389 | 1,325 | 1,096 | 1,020 | 838.33 | 863.59 |
Gross Profit | 387.93 | 400.6 | 333.27 | 293.18 | 231.76 | 273.63 |
Selling, General & Admin | 261.72 | 246.86 | 191.94 | 162.4 | 140.89 | 151.79 |
Other Operating Expenses | 10.01 | 7.65 | 1.34 | 0.6 | 0.1 | -0.02 |
Operating Expenses | 271.96 | 254.73 | 193.51 | 164.38 | 140.01 | 152.32 |
Operating Income | 115.97 | 145.86 | 139.76 | 128.8 | 91.75 | 121.3 |
Interest Expense | -14.05 | -14.05 | -7.85 | -9.69 | -11.69 | -11.56 |
Interest & Investment Income | 4.8 | 4.8 | 11.48 | 15.71 | 7.19 | 3.71 |
Other Non Operating Income (Expenses) | -6.43 | -1.85 | -1.15 | -1.04 | -1.85 | -2.99 |
EBT Excluding Unusual Items | 100.11 | 134.76 | 142.24 | 133.78 | 85.4 | 110.47 |
Gain (Loss) on Sale of Investments | 0.74 | 0.82 | 9.06 | 5.34 | 4.12 | 7.41 |
Gain (Loss) on Sale of Assets | 0.47 | -0.02 | 0.05 | 0.05 | 0.22 | 0.1 |
Asset Writedown | -7.03 | -7.06 | -1.22 | -0.44 | -0.26 | -0.59 |
Legal Settlements | - | - | - | - | - | -4.64 |
Other Unusual Items | -8.87 | -8.87 | 1.26 | -20.43 | 9.82 | 1.43 |
Pretax Income | 85.42 | 119.64 | 151.39 | 118.3 | 99.29 | 114.18 |
Income Tax Expense | 43.91 | 47.31 | 35.81 | 33.77 | 21.92 | 26.8 |
Earnings From Continuing Operations | 41.51 | 72.33 | 115.58 | 84.53 | 77.37 | 87.38 |
Minority Interest in Earnings | 19.39 | 11.86 | -10.55 | -6.29 | -13.92 | -10.68 |
Net Income | 60.9 | 84.18 | 105.03 | 78.24 | 63.45 | 76.69 |
Net Income to Common | 60.9 | 84.18 | 105.03 | 78.24 | 63.45 | 76.69 |
Net Income Growth | -44.58% | -19.85% | 34.24% | 23.31% | -17.27% | 24.22% |
Shares Outstanding (Basic) | 209 | 205 | 206 | 191 | 156 | 154 |
Shares Outstanding (Diluted) | 209 | 205 | 206 | 191 | 156 | 154 |
Shares Change (YoY) | 2.21% | -0.30% | 7.92% | 22.62% | 0.73% | 2.59% |
EPS (Basic) | 0.29 | 0.41 | 0.51 | 0.41 | 0.41 | 0.50 |
EPS (Diluted) | 0.29 | 0.41 | 0.51 | 0.41 | 0.41 | 0.50 |
EPS Growth | -45.78% | -19.61% | 24.39% | 0.56% | -17.87% | 21.77% |
Free Cash Flow | -301.25 | -398.17 | -379.88 | 76 | 62.95 | -23.07 |
Free Cash Flow Per Share | -1.44 | -1.94 | -1.84 | 0.40 | 0.41 | -0.15 |
Dividend Per Share | - | - | 0.148 | 0.073 | - | - |
Dividend Growth | - | - | 102.46% | - | - | - |
Gross Margin | 21.83% | 23.22% | 23.32% | 22.32% | 21.66% | 24.06% |
Operating Margin | 6.53% | 8.46% | 9.78% | 9.81% | 8.57% | 10.67% |
Profit Margin | 3.43% | 4.88% | 7.35% | 5.96% | 5.93% | 6.74% |
Free Cash Flow Margin | -16.95% | -23.08% | -26.58% | 5.79% | 5.88% | -2.03% |
EBITDA | 204.66 | 225.79 | 184.66 | 172.05 | 139.87 | 165.24 |
EBITDA Margin | 11.52% | 13.09% | 12.92% | 13.10% | 13.07% | 14.53% |
D&A For EBITDA | 88.68 | 79.93 | 44.9 | 43.25 | 48.13 | 43.94 |
EBIT | 115.97 | 145.86 | 139.76 | 128.8 | 91.75 | 121.3 |
EBIT Margin | 6.53% | 8.46% | 9.78% | 9.81% | 8.57% | 10.67% |
Effective Tax Rate | 51.40% | 39.55% | 23.65% | 28.55% | 22.07% | 23.47% |
Revenue as Reported | 1,725 | 1,725 | 1,429 | 1,313 | 1,070 | 1,137 |
Advertising Expenses | - | 25.21 | 12.16 | 3.25 | 0.89 | 0.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.